ASTRAZENECA DL-,25 SP.ADR
ASTRAZENECA DL-,25 SP.ADR/ US0463531089 /
ZEGA
20.09.2024 21:26:36
|
Zm.
-0,500
|
Wolumen |
Bid22:00:01 |
Ask22:00:01 |
Kapitalizacja Rynkowa |
St. dywidendy |
Wskaźnik C/Z |
70,000EUR
|
-0,71%
|
0 Obrót: 0.000 |
-Wolumen Bid: - |
-Wolumen Ask: - |
217,93 mldEUR |
- |
- |
Opis działalności
AstraZeneca (LSE/STO/Nasdaq: AZN) is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three therapy areas - Oncology, Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. Based in Cambridge, UK, AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide.
Zarząd & Rada nadzorcza
CEO |
Pascal Soriot |
Zarząd |
Aradhana Sarin, Pam Cheng, Ruud Dobber, Marc Dunoyer, David Fredrickson, Susan Galbraith, Menelas (Mene) Pangalos, Jeff Pott, Iskra Reic, Leon Wang, Sharon Barr |
Rada nadzorcza |
Michel Demaré, Pascal Soriot, Aradhana Sarin, Philip Broadley, Euan Ashley, Deborah DiSanzo, Diana Layfield, Sheri McCoy, Tony Mok, Nazneen Rahman, Andreas Rummelt, Marcus Wallenberg |
Dane firmy
Nazwa: |
AstraZeneca plc |
Adres: |
1 Francis Crick Avenue Cambridge Biomedical Campus,Cambridge, CB2 0AA United Kingdom |
Telefon: |
0800 783 0033 |
Fax: |
+44-20-7604-8151 |
E-mail: |
Medical.InformationU...eca.com
Medical.InformationUK@astrazeneca.com
|
Internet: |
www.astrazeneca.com |
Przemysł: |
Służba zdrowia |
Sektor: |
Przemysł Farmaceutyczny |
Podsektor: |
Przemysł Farmaceutyczny |
Koniec roku finansowego: |
31.12 |
Free float: |
- |
Data IPO: |
06.04.1999 |